Metabolic effects of monoamine oxidase inhibitors on the rat pituitary.
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D001681:Biological Assay; D001835:Body Weight / Q000187:drug effects; D004247:DNA / Q000032:analysis; D004838:Epiphyses; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D013006:Growth Hormone / Q000096:biosynthesis*; D007490:Iproniazid / Q000494:pharmacology*; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology*; D010902:Pituitary Gland / Q000032:analysis / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D012313:RNA / Q000032:analysis; D051381:Rats; D013977:Tibia
D008996:Monoamine Oxidase Inhibitors; D012313:RNA; D013006:Growth Hormone; D004247:DNA; D010293:Pargyline; D007490:Iproniazid; D005954:Glucosephosphate Dehydrogenase; D000469:Alkaline Phosphatase